Intravasation: Difference between revisions
CSV import |
CSV import |
||
| Line 28: | Line 28: | ||
{{stub}} | {{stub}} | ||
{{dictionary-stub1}} | {{dictionary-stub1}} | ||
{{No image}} | |||
Revision as of 01:22, 11 February 2025
Intravasation is a medical term that refers to the process by which cancer cells enter the circulatory system during the progression of the disease. This process is a critical step in metastasis, the spread of cancer from the primary site to other parts of the body.
Overview
Intravasation is a complex process that involves several steps. First, cancer cells detach from the primary tumor and invade the surrounding tissue. They then degrade the extracellular matrix, a network of proteins and carbohydrates that provides structural and biochemical support to cells. This degradation allows the cancer cells to reach the blood vessels.
Once at the blood vessels, the cancer cells adhere to the endothelium, the inner lining of the blood vessels. They then penetrate the endothelium and enter the bloodstream, a process known as intravasation. Once in the bloodstream, the cancer cells can travel to other parts of the body and form secondary tumors.
Mechanisms
The mechanisms of intravasation are not fully understood. However, it is known that several factors can promote this process. These include changes in the cancer cells themselves, such as increased motility and invasiveness, as well as changes in the tumor microenvironment, such as inflammation and angiogenesis.
In addition, certain molecules, known as chemokines, can attract cancer cells to the blood vessels. Other molecules, known as matrix metalloproteinases, can degrade the extracellular matrix and facilitate the invasion of cancer cells.
Clinical significance
Intravasation is a key step in metastasis, which is responsible for the majority of cancer-related deaths. Therefore, understanding the mechanisms of intravasation could lead to the development of new therapies to prevent or treat metastasis.
Several strategies are currently being explored to inhibit intravasation. These include the use of drugs to block the molecules that promote this process, as well as the use of nanoparticles to deliver anti-cancer agents directly to the tumor site.
